11:55 AM

Sponsored by: New Approach to Site ID: Adding a Semantic Knowledge Platform to Solid Process Foundation

This session will explore a roadmap to site ID in one click. We’ll illustrate the importance of strong expertise-driven processes combined with the first-of-its-kind semantic knowledge platform. Using 30 years’ worth of operational data, a solid process foundation, and external data from 500k+ institutions and 3M sites, this new methodology reduces the industry’s 50% non-enrollment rate and empowers sponsors to accelerate timelines, cut costs, and boost trial efficiency.

12:45 PM

Sponsored by: Faster, Better, Smarter: The ROI of Simulation in Clinical Trials

In clinical trials, every dollar, data point, and day counts. This session explores how simulation-based training delivers measurable returns across the three metrics that matter most—cost, quality, and time. Learn how sponsors and sites are using immersive, adaptive learning and simulated protocols to reduce site/patient training burden, improve protocol compliance, and accelerate study timelines—without sacrificing quality. We’ll share case examples, data insights, and practical takeaways to help you turn training from a cost center into a competitive advantage.

3:55 PM

Sponsored by: Standardizing for Speed: The Blueprint for Modern Sponsor Site Partnership

Discover how leading biopharmas are strengthening their site partnerships through people, processes and platforms. Panelists from pharma, tech, and site networks will share how they are adopting standardized collaboration models-including restructuring roles and processes to foster genuine relationships and drive operational excellence.

Key Takeaways:

• Relationship Focus: Dedicated roles to build trust and ensure seamless execution

• Harmonization and Standardization: Streamlined surveys and unified systems to reduce redundancy.

• Operational Excellence: Leveraging standardized technology to improve efficiency and accelerate site activation.

4:20 PM

Sponsored by: Maximizing Impact for Sites Running Decentralized & Hybrid Clinical Trials

Decentralized and hybrid clinical trials enable sites to extend beyond traditional settings through community-based and in-home visit models. Maximizing impact depends on strong site engagement, early alignment, and clear communication to support efficient study start-up and delivery. Early engagement builds shared understanding of protocol needs and workflows, enabling practical, tailored solutions. These approaches have proven to expand geographic reach, reduce patient burden, improve retention and compliance, and help sites optimize recruitment, operations, and data quality while delivering patient-centered trials.

5:10 PM

Sponsored by: Powering Smarter Site Selection and Study Start-Up with Platform Technology

In this session, Catherine Gregor, Chief Clinical Trial Officer at Florence Healthcare, will share how organizations are rethinking site identification and feasibility using global site intelligence and AI-driven scoring to improve site selection. She’ll also examine the execution gap between selection and activation, showing how AI-first workflows reduce delays, risk, and manual handoffs while improving site readiness and speeding trial activation.

8:00 AM

BREAFAST PRESENTATION OPTION #1:
Sponsored by: Reaching the Unreachable: Proven Strategies You Can Apply to Engage Underserved Populations in Global Clinical Trials

Underserved populations are often excluded from clinical trials, limiting engagement, scientific validity, and real-world relevance. Traditional strategies often rely on outdated assumptions and overlook patient realities. This session reveals proven, globally scalable strategies to engage these communities through real-world data (RWD), behavioral insights, and human-centered approaches—replacing guesswork with precision to accelerate inclusive trial enrollment and shorten study timelines.

8:00 AM

BREAKFAST PRESENTATION OPTION #2:
Sponsored by: From Elusive to Enrolled: A Case Study in Precision Recruitment 

As the pace of innovation accelerates, scientific breakthroughs bring new hope to patients. Effectively including and supporting underrepresented populations is critical for the success of clinical trials designed to benefit these communities. GCI Health’s experts will share their “secret sauce” for building meaningful engagement with niche communities along with a real-world example of its methodology in action through its work with the University of Florida’s traumatic brain injury trial.

8:35 AM

Sponsored by: Aligning Stakeholder Priorities: A Unified Performance Framework for Clinical Trial Success

Clinical trials involve diverse stakeholders with competing priorities, often causing misaligned incentives and communication gaps that delay patient access to therapies. This interactive panel unites sponsor, site, and CRO perspectives to explore a unified performance measurement framework. Panelists will share strategies for transparency, accountability, and alignment to accelerate access while ensuring quality and compliance.

9:50 AM

Sponsored by: Meeting Sites Where They Are—Key Connections in Action

Accelerating study start-up and improving operational outcomes requires sponsors to support sites within their established ways of working. This session explores how connected and easily accessible technology with aligned workflows can reduce inefficiencies, strengthen collaboration, and enhance visibility across study operations. Through real-world examples, we’ll highlight how greater technological harmony between stakeholders contributes to more efficient start-up, stronger engagement, and the realization of connected research.

8:00 AM

BREAKFAST PRESENTATION:
Sponsored by: From Burden to Breakthrough: Innovative Strategies for Site and Patient Support

This presentation explores strategies to strengthen clinical trial site capacity and improve patient engagement. It emphasizes delivering customized solutions through specialized roles that integrate with site teams, flexible resourcing, and operational support across key activities such as prescreening, recruitment, data entry, and remote study visits. Additionally, it highlights the importance of global scalability combined with local expertise, supported by an oversight structure that ensures consistency worldwide. The ultimate goal is to drive measurable improvements in site performance, operational efficiency, patient engagement, and retention, creating a more effective and patient-centric trial experience.

9:00 AM

Sponsored by: AI & Innovation in Clinical Trial Financial Management

Join industry leaders to discover how innovation is transforming clinical trial financial management and accelerating site and patient success. Hear firsthand about the key features and tools they’re most excited to implement and get an insider’s look at early improvements, including streamlined payment automation and stronger site outcomes. Whether you’re exploring AI in clinical trial financial management or seeking ways to boost results for sites and patients, this session delivers forward-looking insights and practical lessons from the field.

9:50 AM

Sponsored by: Empirical Impact of Protocol Complexity on Enrollment Speed and Patient Withdrawal in Clinical Trials

We developed a multi-dimensional, quantitative framework to measure protocol complexity and applied it to digitized data from thousands of clinical trials conducted over the past decade. Using empirical models, we quantified how specific complexity dimensions influence enrollment speed and patient-initiated withdrawal. Scenario-based analyses demonstrate how targeted protocol simplification can improve operational performance and support more efficient prospective trial design.

12:00 PM

Sponsored by: Optimizing Clinical Trials: Leveraging Payer Insights and Real-World Data for Recruitment and Site Planning

In an industry where 85% of clinical trials fail to recruit or retain enough participants, precision targeting is crucial. This session explores how robust pharmacy and medical claims data – enhanced by payer insights – can be used to rapidly identify patient cohorts that match detailed study criteria and pinpoint where those patients reside. By leveraging real-world data and payer insights in study planning, sponsors can avoid protocol revisions and costly delays. Attendees will learn how a data-driven approach to clinical criteria and site selection ensures that only the most relevant patients enter the pipeline. Attendees will learn how data-driven clinical criteria and site selection ensures only the most relevant patients enter the pipeline, and they will understand how payer-informed targeting and outreach improves speed, scalability and overall trial performance.